30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

DJO Joint Replacement Growth Driven by New Products -

DJO reported 3Q19 orthopedic revenue of USD $97.9MM, +5.9% vs. 3Q18.

 

  • Colfax leadership says it is off to a strong start implementing operational efficiencies at DJO through their CBS program
  • Surgeon conversions and new products like the AltiVate shoulder, EMPOWR Knee and AltiVate Reverse Short Stem drove joint replacement revenue growth
  • Leadership believes it can sustain consistent high single-digit growth for joint replacement
  • The company is actively working a “healthy funnel” of bolt-on acquisitions to accelerate growth in 2020
  • ORTHOWORLD projects DJO full year 2019 orthopedic revenue of $411.2MM, +5.5% vs. 2018

 

ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).

  3Q19 3Q18 $ Chg % Chg
Joint Replacement $75.9 $70.9 $5.0 7.1%
   Knees $19.5 $18.5 $1.0 5.6%
   Hips $16.7 $16.1 $0.7 4.3%
   Extremities $39.6 $36.4 $3.3 9.0%
Other (Recovery Sciences) $22.0 $21.5 $0.5 2.3%
Total $97.9 $92.4 $5.5 5.9%
  9Mo 19 9Mo 18 $ Chg % Chg
Joint Replacement $230.5 $217.7 $12.7 5.9%
   Knees $59.9 $56.8 $3.1 5.5%
   Hips $51.0 $49.3 $1.7 3.5%
   Extremities $119.5 $111.6 $7.9 7.1%
Other (Recovery Sciences) $64.4 $65.5 -$1.1 -1.6%
Total $294.9 $283.2 $11.7 4.1%

 

Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.